NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 35 filers reported holding NOVELION THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,015,000 | -27.7% | 1,400,000 | -22.2% | 1.83% | -30.4% |
| Q2 2019 | $1,404,000 | -36.6% | 1,800,000 | 0.0% | 2.63% | -69.1% |
| Q1 2019 | $2,214,000 | +43.0% | 1,800,000 | 0.0% | 8.53% | +41.8% |
| Q4 2018 | $1,548,000 | -48.3% | 1,800,000 | +78.0% | 6.02% | -16.9% |
| Q3 2018 | $2,994,000 | -38.1% | 1,011,487 | -23.0% | 7.24% | -47.1% |
| Q2 2018 | $4,833,000 | +38.1% | 1,313,387 | +31.3% | 13.70% | -5.8% |
| Q1 2018 | $3,500,000 | +12.2% | 1,000,000 | 0.0% | 14.55% | +53.3% |
| Q4 2017 | $3,120,000 | -49.7% | 1,000,000 | +13.5% | 9.49% | -23.5% |
| Q3 2017 | $6,197,000 | -19.2% | 881,440 | +6.0% | 12.40% | -10.1% |
| Q2 2017 | $7,674,000 | -14.1% | 831,440 | 0.0% | 13.79% | -9.7% |
| Q1 2017 | $8,930,000 | +27.6% | 831,440 | 0.0% | 15.27% | +103.7% |
| Q4 2016 | $7,001,000 | – | 831,440 | – | 7.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 1,800,000 | $1,404,000 | 2.63% |
| Stonepine Capital Management, LLC | 491,096 | $383,000 | 0.26% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 918,342 | $716,000 | 0.05% |
| KNOTT DAVID M | 109,135 | $85,000 | 0.04% |
| EdgePoint Investment Group Inc. | 2,831,555 | $2,209,000 | 0.02% |
| Yakira Capital Management, Inc. | 36,428 | $28,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 46,000 | $36,000 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 85,409 | $66,000 | 0.00% |
| FARMERS & MERCHANTS INVESTMENTS INC | 191 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 37,717 | $29,000 | 0.00% |